The three risk classes, how FDA decides which one your device is, the market pathways, and what every class must do.
| Class I | Class II | Class III | |
|---|---|---|---|
| Risk | Low | Moderate | High |
| Controls | General controls | General + special controls | General controls + PMA |
| Pathway | Usually 510(k)-exempt | Usually 510(k) | Usually PMA |
| FDA action | Listed (often no submission) | Cleared (substantial equivalence) | Approved (safety + effectiveness) |
| Examples | Bandages, exam gloves, tongue depressors | Catheters, tampons, pregnancy tests, infusion pumps | Pacemakers, heart valves, implants |
A device's class isn't based on appearance — it's based on intended use and indications for use, plus risk, technology, patient contact, invasiveness, duration, energy source, software function, and how similar devices are regulated.
Whatever the class, the general controls apply:
FDA Registration Assistance reviews your device's intended use and indications, identifies the likely product code and class, and flags the pathway (exempt, 510(k), De Novo, or PMA) and any special controls — then handles FDA establishment registration, device listing, and U.S. Agent support, and coordinates importer obligations. We work with manufacturers, foreign establishments, importers, distributors, and private-label brands.
Contact us at info@fdaregistrationassistance.com or call +1 (928) 275-8333 for a quote. An independent compliance firm serving 1,000+ companies across 135+ countries, with 15+ years of experience.
They are FDA's three risk-based device classes, defined by the level of control needed to give reasonable assurance of safety and effectiveness. Class I is generally lower risk (general controls; most are 510(k)-exempt - e.g., bandages, exam gloves, tongue depressors). Class II is moderate risk (general controls plus special controls; most require 510(k) clearance - e.g., catheters, tampons, pregnancy test kits, infusion pumps). Class III is highest risk (general controls plus premarket approval/PMA - e.g., pacemakers, heart valves, implants). The class sets the market pathway.
By the device's intended use and indications for use, plus risk, technology, patient contact, invasiveness, duration of use, and how similar devices are already regulated. FDA organizes classifications by 16 medical specialty panels (21 CFR Parts 862–892); each device type has a product code and a classification regulation number that state its class, any special controls, and its exemption status. Classification should be based on the regulation and product code - not on appearance or marketing preference.
No. Most Class I devices are exempt from 510(k), but that is not the same as exempt from all requirements. General controls still apply: establishment registration and device listing (where the establishment role requires it), compliant labeling, the applicable quality system provisions, complaint handling, Medical Device Reporting, and import requirements. "Class I" and "510(k)-exempt" do not mean "no FDA obligations." Verify the specific exemption and the remaining duties.
Yes - most Class II devices require a 510(k) premarket notification before marketing, unless a specific exemption applies. A 510(k) demonstrates the device is substantially equivalent to a legally marketed predicate device. Class II devices also carry special controls (device-specific performance standards, testing, labeling, or postmarket requirements) on top of general controls. Registration and listing are not a substitute for 510(k) clearance when clearance is required.
Generally yes. Class III devices - those that support or sustain life, are implanted, or present a potential unreasonable risk - usually require premarket approval (PMA) under 21 CFR Part 814, FDA's most stringent pathway. A PMA must show reasonable assurance of safety and effectiveness with valid scientific evidence, typically including clinical data, plus manufacturing and quality detail. Class III should be identified early because the PMA pathway is far more demanding than 510(k).
General controls apply to all devices (registration, listing, quality system/GMP, labeling, Medical Device Reporting, and prohibitions against misbranding/adulteration). Special controls are additional, device-specific requirements that distinguish Class II from Class I - things like performance standards, specific bench or clinical testing, special labeling, patient registries, or postmarket surveillance, tailored to the particular risks of that device type. Class III adds premarket approval on top of general controls.
De Novo (21 CFR Part 860, Subpart D) is a classification pathway for novel devices that are low-to-moderate risk but have no suitable predicate to support a 510(k). Rather than defaulting into Class III for lack of a predicate, a sponsor can request that FDA create a new Class I or Class II category (with special controls if Class II). A granted De Novo becomes a predicate that later devices of the same type can cite in a 510(k). It's common for digital health and novel technologies.
The general controls apply across all classes: FDA establishment registration (21 CFR Part 807, annual) and device listing; a quality system (21 CFR Part 820, transitioning to the QMSR, which harmonizes with ISO 13485 - compliance date February 2, 2026; most Class I devices are exempt from the design-control provisions); Medical Device Reporting (21 CFR Part 803) for deaths, serious injuries, and malfunctions; compliant labeling (21 CFR Part 801); and prohibitions against misbranding and adulteration. Foreign establishments also need a U.S. Agent.
They are not interchangeable. "510(k)-cleared" means FDA found the device substantially equivalent to a predicate - it's a clearance, used for most Class II devices. "PMA-approved" means FDA approved the device based on evidence of safety and effectiveness - reserved for high-risk Class III devices. So a 510(k) device is cleared, not approved, and only PMA (Class III) devices are "FDA-approved." Using "approved" for a cleared device is a common and meaningful error.
A product code is FDA's specific identifier for a device type; it links the device to its classification regulation number, class, submission type, and applicable controls. The device class is the risk category. Finding the right product code (via FDA's Product Classification Database, based on intended use) is how you confirm the class, whether 510(k)/De Novo/PMA/exemption applies, and any special controls. Selecting the wrong product code causes listing, import, and strategy problems.
Yes. Classification is not based on appearance. Two similar-looking products can fall into different classes if they have different intended uses, indications, technology, patient populations, energy sources, software functions, or clinical settings. A claim or feature that raises new safety/effectiveness questions can move a product to a higher class or a different product code - which is why the intended use and claims must be pinned down before classifying.
Yes. FDA determines intended use from the full presentation - labels, instructions, website, online listings, brochures, and advertising - not just the package. Adding a disease, diagnostic, treatment, or clinical-performance claim can move a product into a more demanding pathway (or make a non-device into a device). Review all consumer- and buyer-facing claims before launch, because claims can change the class and the required submission.
No. Establishment registration and device listing are administrative requirements - they put your establishment and products in FDA's system. They do not mean FDA reviewed, cleared, or approved the device, and they are not a substitute for a required 510(k), De Novo, or PMA. A company can be registered while its device is not lawfully marketed because a required premarket submission hasn't been obtained. Registration is not clearance.
Yes. Software can be a medical device (Software as a Medical Device) depending on its intended use and function. Software that analyzes medical data, supports diagnosis, recommends treatment, monitors patients, or controls another device may be regulated, and its class depends on risk and clinical impact - some are Class I or II, some higher. Many novel software/AI devices use the De Novo pathway. Classification review is essential for digital health products.
As early as possible - before finalizing claims, designing labeling, printing packaging, filing registration, listing the device, booking a shipment, launching an e-commerce listing, or signing a distributor agreement. Classification drives the entire pathway, so confirming the class and product code first prevents expensive rework (reprinting packaging, added testing, detained shipments, marketplace removals) that happens when a classification problem is discovered after production begins.
We help review a device's intended use and indications, identify the likely product code and class, and flag the pathway (exempt, 510(k), De Novo, or PMA) and any special controls - then handle FDA establishment registration, device listing, and U.S. Agent support, and coordinate importer obligations. We work with manufacturers, foreign establishments, importers, distributors, private-label brands, and specification developers entering the U.S. market. We're an independent compliance firm serving 1,000+ companies across 135+ countries with 15+ years of experience. Contact info@fdaregistrationassistance.com or +1 (928) 275-8333.